ConductScience.org, home

Cell line · CVCL_0419

MDA-MB-468

Cancer cell line, Homo sapiens. Breast adenocarcinoma. 290 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Download JSON
Cite this record

ConductScience Library. MDA-MB-468. Cell lines, record CVCL_0419. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0419

On this page

Cell line

As Cellosaurus gives it.

Name
MDA-MB-468
Accession
CVCL_0419
RRID
RRID:CVCL_0419
Synonyms
MDA-MB 468, MDA-MB468, MDAMB468, MDA-468, MDA468, MB468, MD Anderson-Metastatic Breast-468
Species
Homo sapiens (Human)
Sex
Female
Age at sampling
51Y
Category
Cancer cell line
Diseases
Breast adenocarcinoma (NCIt C5214)
Derived from
Pleural effusion (metastatic)
Entry created
2012-04-04
Entry updated
2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers290

1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.

PaperJournalYearHow we knowRetractedSource
Comprehensive characterization of the cellular and molecular consequences of LCN2 loss in MDA-MB-231 triple-negative breast cancer cellsFront Cell Dev Biol2026Its Methods give the RRID and name the linePubMed
Overcoming platinum resistance by the disulfiram metabolite CuET in novel preclinical models of human carcinomas.Mol Oncol2026Its Methods give the RRID and name the linePubMed
ESR1 mutations are associated with enhanced MTORC1 signaling in a context-dependent manner.Commun Biol2026Its Methods give the RRID and name the linePubMed
Lysyl oxidase inhibition disrupts mitochondrial homeostasis to create vulnerability to ferroptosis in TNBC.Cell Rep Med2026Its Methods give the RRID and name the linePubMed
CRB-701: A Second-generation Nectin-4-Targeted Antibody-Drug Conjugate with Optimized Stability and Pharmacokinetics for the Treatment of Solid Tumors.Cancer Res Commun2026Its Methods give the RRID and name the linePubMed
Role of orphan G protein-coupled receptor GPR52 in breast cancer cell multicellular organization and collective invasion.Br J Cancer2026Its Methods give the RRID and name the linePubMed
HSPA8 globally modulates transcriptome profile and PI3K/AKT signaling pathway to facilitate malignant progression phenotypes of triple-negative breast cancer.Sci Prog2026Its Methods give the RRID and name the linePubMed
Meditope-Enabled Chimeric Antigen Receptors Facilitate Plug-and-Play Control of T Cells.Cancer Immunol Res2026Its Methods give the RRID and name the linePubMed
An antibody-PROTAC conjugate targets BRD4/c-Myc/PD-L1 to enhance immunotherapy efficacy in triple-negative breast cancer.Cell Rep Med2026Its Methods give the RRID and name the linePubMed
Broad-Spectrum Antibiotics Attenuate the Chemotherapeutic Efficacy of Doxorubicin in MDA-MB-468 Breast Cancer Cells.Int J Breast Cancer2026Its Methods give the RRID and name the linePubMed

1 to 10 of 290

See all 290 papers

Relatives14

RelationCell lineAccessionProblemSource
Derived from itCellSensor DBE-bla MDA-MB-468CVCL_KS13Cell lines
Derived from itHyCyte MDA-MB-468 KO-hRALACVCL_F4HVCell lines
Derived from itHyCyte MDA-MB-468-LucCVCL_E3HYCell lines
Derived from itMDA-MB-468 shPARGCVCL_RA91Cell lines
Derived from itMDA-MB-468 shWDR12-4CVCL_YJ27Cell lines
Derived from itMDA-MB-468(Cas9)CVCL_E7JBCell lines
Derived from itMDA-MB-468-LucCVCL_C8XWCell lines
Derived from itMDA-MB-468/Cas9-hygCVCL_C9CFCell lines
Derived from itMDA-MB-468/GFPCVCL_JZ00Cell lines
Derived from itMDA-MB-468GFPCVCL_DH83Cell lines

Cell banks12

Cell bankCatalog numberStatusSource
ATCCHTB-132ATCC
AddexBioC0006003/4673Cellosaurus
BCRJ0166BCRJ
CLS300279CLS
DSMZACC-738DSMZ
HysigenTCH-C253Hysigen
IBRCC10095Cellosaurus
ICLCHTL99024ICLC
KCBKCB 2011114YJCellosaurus
NCBI_IranC208Cellosaurus

Data dates

The date of each source this release read.

Cellosaurus
2026-10-22
Cellosaurus
PubMed Central's articles
2026-11-12
PubMed Central's articles
Our copy of PubMed
2026-11-06
Our copy of PubMed

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0419

GET https://conductscience.org/api/cell-lines/v1/CVCL_0419/papers?page=2